Summary
The evaluation of rabies vaccine potency is of great importance to those who are concerned with the manufacture or the control of this vaccine.
This evaluation can be done by different methods which do not test the same thing. In vitro methods (ABT — SRD — RIA) permit the determination of the glycoprotein content and in vivo methods give a good idea of the glycoprotein immunogenic activity then is the reflect of the protective activity which is not necessarily the case for in vitro method.
The N.I.H. test is not adapted for in-process control of rabies vaccine during manufacture, but in vitro methods could be very useful for this work if a good correlation existed between in vitro assays and in vivo assays.
The purpose of this study is to compare the potency results obtained with in vitro and in vivo methods for about 80 batches of rabies vaccine produced on human diploid cells.
Résumé
L’évaluation de l’efficacité du vaccin antirabique a une grande importance pour tous ceux qui sont concernés par sa fabrication ou par son contrôle.
Cette évaluation peut être faite soit par des méthodes in vitro (ABT — SRD — RIA) soit par une méthode in vivo (test NIH).
L’objet de cette étude est de comparer les résultats d’activité obtenus avec les méthodes in vitro et in vivo sur 78 lots de vaccin antirabique produits sur cellules diploïdes humaines.
Les résultats montrent que les méthodes in vivo et in vitro classent les différents vaccins dans le même ordre, que les 3 techniques in vitro donnent une notion assez exacte de la valeur qui sera obtenue par le test NIH.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Arko RJ, Wiktor TJ, Sikes RK (1973) The antibody binding test for vaccine potency. Laboratory techniques in rabies, 3rd ed. W.H.O. Geneva p. 292
Barth R, Jaeger O (1979) Zentralblatt für Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene 169, 488–494
Cox JH, Dietzschold B, Schneider LG (1977) Rabies virus glycoprotein II Biological and Serological characterization. Infection and Immunity 16, 754–759
Schild GC, Wood JM, Newman RW (1975) A single radial immunodiffusion technique for the assay of Influenza haemagglutinin antigen. Bulletin of the W.H.O. 52, 157–170.
Schild GC, Ferguson M (1982) A single radial immunodiffusion technique for the assay of rabies glycoprotein antigen: application for potency tests of vaccines against rabies. J. Gen. Viral. 59, 197–201
Seligman EB (1973) The NIH test for potency. In laboratory technics in rabies 3rd W.H.O. p. 279–286
Wiktor TJ et al. (1978) Comparison studies on potency tests for rabies vaccine. Development in biological standardization 40, 171–178
Wiktor TJ (1983) Fournier Direct determination of antigenic potency of rabies vaccines by binding of monoclonal antibodies to glycoprotein in radioimmunoassay. Rabies Information Exchange — published by C.D.C. Atlanta
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Springer-Verlag Berlin, Heidelberg
About this paper
Cite this paper
Vincent-Falquet, J.C., Callard, R., Souvras, M., Xueref, C., Gibelin, N., Peyron, L. (1985). In Vitro Determination of Antigenic Potency of Rabies Vaccine and Comparison with N.I.H. Test. In: Kuwert, E., Mérieux, C., Koprowski, H., Bögel, K. (eds) Rabies in the Tropics. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70060-6_41
Download citation
DOI: https://doi.org/10.1007/978-3-642-70060-6_41
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-13826-6
Online ISBN: 978-3-642-70060-6
eBook Packages: Springer Book Archive